Nirmatrelvir‐ritonavir therapy and COVID‐19 vaccination improve clinical outcomes of SARS‐CoV‐2 Omicron variant infection

To evaluate the effect of Nirmatrelvir‐ritonavir therapy and coronavirus disease 2019 (COVID‐19) vaccination on clinical outcomes of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron infection, we retrospectively analyzed the clinical data of 762 adult patients with confirmed Omic...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Tangkai, Jin, Yinpeng, Wang, He, Liao, Yixin, Liu, Tiefu, Mao, Enqiang, Li, Feng, Li, Yinchuan, Fan, Xiaohong, Ling, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107277/
https://www.ncbi.nlm.nih.gov/pubmed/36651302
http://dx.doi.org/10.1002/jmv.28497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107277/
https://www.ncbi.nlm.nih.gov/pubmed/36651302
http://dx.doi.org/10.1002/jmv.28497

Ejemplares similares